CSIMarket Company Name, Ticker, Industry, else..
 
Adagio Medical Holdings inc   (NASDAQ: ADGM)
 
Price: $0.5302 $0.00 0.417%
Day's High: $0.539900004863739 Week Perf: 1.57 %
Day's Low: $ 0.53 30 Day Perf: 15.26 %
Volume (M): 23,851 52 Wk High: $ 2.58
Volume (M$): $ 0 52 Wk Avg: $1.03
Open: $0.54 52 Wk Low: $0.36



 Market Capitalization (Millions $) 12
 Shares Outstanding (Millions) 22
 Employees 41
 Revenues (TTM) (Millions $) -
 Net Income (TTM) (Millions $) -2
 Cash Flow (TTM) (Millions $) -6
 Capital Exp. (TTM) (Millions $) 1

Business Description


The company develops and commercializes catheter-based Ultra-Low Temperature Ablation (ULTA) technology for treating cardiac arrhythmias, with a focus on ventricular tachycardia (VT). Their proprietary ULTA products are designed to create large, durable lesions in the heart's ventricles to improve VT ablation outcomes. The company has obtained CE Mark approval for its vCLAS Cryoablation System and is conducting pivotal FDA trials in the United States. Additionally, it is developing next-generation ULTA catheters and Pulsed Field Cryoablation (PFCA) technology for the treatment of VT and atrial fibrillation.


   Company Address: 26051 Merit Circle Laguna Hills 92653 CA
   Company Phone Number: 348-1188   Stock Exchange / Ticker: NASDAQ ADGM


   

Stock Performances by Major Competitors

5 Days Decrease / Increase
     
ATEC   -1.29%    
ATRC        0.49% 
CNMD   -3.64%    
EW   -0.14%    
IART   -1.01%    
ISRG   -0.7%    
• View Complete Report
   



Business Update

Navigating Arrhythmia Adagio Medicals Strategic Balancing Act in a Competitive Landscape,

Published Wed, Nov 5 2025 3:53 PM UTC

Adagio Medical Holdings: Striving for Rhythm Amidst Cardiac Technology Competition In a rapidly evolving landscape of medical innovation, Adagio Medical Holdings, Inc. (Nasdaq: ADGM) has emerged as a noteworthy player in catheter ablation technologies, addressing cardiac arrhythmias, a pivotal concern in global healthcare. Next month, Adagio will be under the spotlight as it...
Business Update

Adagio Medical Secures CE Mark Approval and Launches Breakthrough Catheter Ablation Technology to Transform VT Trea...

Published Mon, Aug 19 2024 9:37 PM UTC

LAGUNA HILLS, California Adagio Medical Holdings, Inc. (Nasdaq: ADGM), a frontrunner in the development of catheter ablation technologies aimed at treating cardiac arrhythmias, has announced significant business updates that signal a promising trajectory for the company and its innovative products. These updates highlight the company’s commitment to advancing treatment ...



Fundamental Analysis

Valuation Current
Price to Earnings PE Ratio (TTM) -
Price to Earnings PE Ratio (Expected) -
Price to Sales (TTM) -
Price to Sales (Expected) -
Price to Book -
PEG (TTM) -

Financial Strength Current
Quick Ratio 1.02
Working Capital Ratio 1.41
Leverage Ratio (MRQ) -
Total Debt to Equity -
Interest Coverage (TTM) -
Debt Coverage (TTM) 0.19

Per Share Current
Earnings (TTM) -1.37 $
Revenues (TTM) -
Cash Flow (TTM) -
Cash 0.35 $
Book Value -
Dividend (TTM) 0 $

Efficiency Current
Revenue per Employee (TTM) -
Net Income per Employee (TTM) -50,049
Receivable Turnover Ratio (TTM) -
Inventory Turnover Ratio (TTM) -
Asset Turnover Ratio (TTM) -

Profitability Ratios Current
Gross Margin (MRQ) -
Operating Margin (MRQ) -
Net Margin (MRQ) -
Net Cash Flow Margin (MRQ) -
Effective Tax Rate (TTM) -

Management Effectiveness Current
Return On Assets (TTM) -
Return On Investment (TTM) -
Return On Equity (TTM) -
Dividend Yield -
Pay out Ratio (TTM) -






Help

About us

Products

Data downloads

API

CSIMarket Company, Sector, Industry, Market Analysis, Stock Quotes, Earnings, Economy, News and Research.

Intraday data delayed per exchange requirements. All quotes are in local exchange time. Intraday data delayed 15 minutes for Nasdaq, and other exchanges. Fundamental and financial data for Stocks, Sector, Industry, and Economic Indicators provided by CSIMarket.com

Disclaimer: Information provided by CSIMarket.com is for informational purposes only and does not constitute investment advice, recommendation, or solicitation to buy or sell any security.

© 2026 CSIMarket.com — Proprietary financial dataset. All rights reserved. Redistribution or automated extraction prohibited.